Biotech | December 08, 2025
Freenome strikes SPAC deal to go public in 2026
Freenome expects the combined company to receive approximately $330 million in proceeds at closing
Freenome expects the combined company to receive approximately $330 million in proceeds at closing
Sigachi Industries has reported total income of Rs. 112.97 crore during the period ended September 30, 2025
Nuvaxovid is the only protein-based, non-mRNA COVID-19 vaccine available in the U.S. for the 2025-2026 vaccination season
Laurus Labs has reported total income of Rs. 1,580 crores during the period ended June 30, 2025
RPG Life Sciences has reported total income of Rs. 174.15 crores during the period ended June 30, 2025
Group sales came in at 47.637 billion euros, down 1.2% on a currency- and portfolio-adjusted basis
In 2030 over 50% of FDA approvals will involve AI discovered and developed drugs
Need to harmonize traditional and modern medicine to combat alarming health problems
Syngene will also build and operate a new dedicated drug development laboratory to accelerate the advancement of Amgen R&D projects
A new market study published by Global Industry Analysts (GIA), released its report titled, ``Healthcare Supply Chain Management—Global Market Trajectory & Analytics.’’ We present excerpts from the report
Subscribe To Our Newsletter & Stay Updated
